Bloodborne Pathogens Hepatitis B Vaccination – Declination Statement
... The University of Louisiana at Monroe ...
... The University of Louisiana at Monroe ...
1. Precaution Lymphocytic choriomeningitis (LCM) is a rodent
... Of special note, tumors may acquire LCMV as an adventitious virus without obvious effects on the tumor. Virus may survive freezing and storage in liquid nitrogen for long periods. When infected tumor ce ...
... Of special note, tumors may acquire LCMV as an adventitious virus without obvious effects on the tumor. Virus may survive freezing and storage in liquid nitrogen for long periods. When infected tumor ce ...
200607b_NTU-EN101
... bacterial or viral infection, parasitic infestation, alcohol, drugs, toxins, or transfusion of incompatible blood. ...
... bacterial or viral infection, parasitic infestation, alcohol, drugs, toxins, or transfusion of incompatible blood. ...
QUIZ: Viruses, Viroids and Prions
... 8. ______ an infectious particle that interferes with protein folding, but has no DNA of its own 9. ______ the most convenient metric unit for measuring the relative size of virus particles 10. ______ cell or organism that is infected by a virus 11. ______ a virus that infects plants 12. ______ an i ...
... 8. ______ an infectious particle that interferes with protein folding, but has no DNA of its own 9. ______ the most convenient metric unit for measuring the relative size of virus particles 10. ______ cell or organism that is infected by a virus 11. ______ a virus that infects plants 12. ______ an i ...
Chapter 29: Clinical Virology
... Describe the characteristics of viruses and differentiate them from bacteria. List the steps in virus replication. Describe the proper procedures for collection and transport of viral specimens. Name the appropriate specimen for maximum recovery of suspected viral agent(s). Compare the different met ...
... Describe the characteristics of viruses and differentiate them from bacteria. List the steps in virus replication. Describe the proper procedures for collection and transport of viral specimens. Name the appropriate specimen for maximum recovery of suspected viral agent(s). Compare the different met ...
HEPATITIS B VACCINATION DECLINATION FORM Date:
... I understand that due to my occupational exposure to blood or other potential infectious materials I may be at risk of acquiring Hepatitis B virus (HBV) infection. I have been given the opportunity to be vaccinated with Hepatitis B vaccine, at no charge to myself. However, I decline the Hepatitis B ...
... I understand that due to my occupational exposure to blood or other potential infectious materials I may be at risk of acquiring Hepatitis B virus (HBV) infection. I have been given the opportunity to be vaccinated with Hepatitis B vaccine, at no charge to myself. However, I decline the Hepatitis B ...
HEPATITIS B VACCINE DECLINATION (MANDATORY if decline vaccination)
... be at risk of acquiring a hepatitis B virus (HBV) infection. I have been given the opportunity to be vaccinated with hepatitis B vaccine, at no charge to myself. However, I decline hepatitis B vaccination at this time. I understand that by declining this vaccine, I continue to be at risk of acquirin ...
... be at risk of acquiring a hepatitis B virus (HBV) infection. I have been given the opportunity to be vaccinated with hepatitis B vaccine, at no charge to myself. However, I decline hepatitis B vaccination at this time. I understand that by declining this vaccine, I continue to be at risk of acquirin ...
Hepatitis B Infections Asymptomatic Cases 50% Symptomatic Cases
... Some people with Hep B never fully recover from the infection (chronic infection) They still carry the virus and can infect others for the rest of their lives ...
... Some people with Hep B never fully recover from the infection (chronic infection) They still carry the virus and can infect others for the rest of their lives ...
Hepatitis
... Some people who are infected may not feel the affects of the disease but they are still susceptible to other chronic liver diseases Diagnosis: blood tests/ liver biopsy Treatment: Patient may be prescribed pegylated interferon and ribavirin. ...
... Some people who are infected may not feel the affects of the disease but they are still susceptible to other chronic liver diseases Diagnosis: blood tests/ liver biopsy Treatment: Patient may be prescribed pegylated interferon and ribavirin. ...
Hepatitis B Letter of Declination
... I understand that due to my occupational exposure to human blood, bodily fluids or other potentially infectious materials, I may be at risk of exposure to the Hepatitis B virus (HBV) and consequently, Hepatitis B infection. I have been offered the Hepatitis B vaccine, at no charge to me. However, I ...
... I understand that due to my occupational exposure to human blood, bodily fluids or other potentially infectious materials, I may be at risk of exposure to the Hepatitis B virus (HBV) and consequently, Hepatitis B infection. I have been offered the Hepatitis B vaccine, at no charge to me. However, I ...
Blood Borne Pathogens
... * Micro-organisms present in human blood that can cause disease Viruses, bacteria, parasites, fungi * Primary workplace pathogens Human immunodeficiency virus (HIV) Does not survive long outside the body No cure Hepatitis B virus (HBV) 1 million people infected No cure Can survive outside the body f ...
... * Micro-organisms present in human blood that can cause disease Viruses, bacteria, parasites, fungi * Primary workplace pathogens Human immunodeficiency virus (HIV) Does not survive long outside the body No cure Hepatitis B virus (HBV) 1 million people infected No cure Can survive outside the body f ...
Hepatitis B Vaccine Declination Form
... materials I may be at risk of acquiring Hepatitis B virus (HBV) infection. I have been given the opportunity to be vaccinated with Hepatitis B vaccine, at no charge to myself. However, I decline Hepatitis B vaccination at this time. I understand that by declining this vaccine, I continue to be at ri ...
... materials I may be at risk of acquiring Hepatitis B virus (HBV) infection. I have been given the opportunity to be vaccinated with Hepatitis B vaccine, at no charge to myself. However, I decline Hepatitis B vaccination at this time. I understand that by declining this vaccine, I continue to be at ri ...
Hepatitis Terminology ABBREVIATION TERM COMMENTS
... Detectable at onset of symptoms; lifelong persistence Indicates recent infection with hepatitis A; tests positive up to 4-6 months after infection Etiologic agent of “serum” or “long incubation” hepatitis; also known as Dane particle Surface antigen(s) of HBV detectable in large quantity in serum; s ...
... Detectable at onset of symptoms; lifelong persistence Indicates recent infection with hepatitis A; tests positive up to 4-6 months after infection Etiologic agent of “serum” or “long incubation” hepatitis; also known as Dane particle Surface antigen(s) of HBV detectable in large quantity in serum; s ...
MONONUCLEOSIS
... disease can experience mild to severe illness. Most cases of infectious mononucleosis go away by themselves over 2-3 weeks. During the course of the illness, patients often have days when they feel well, alternating with days when they feel ill. Signs and Symptoms: The viral infection symptoms inclu ...
... disease can experience mild to severe illness. Most cases of infectious mononucleosis go away by themselves over 2-3 weeks. During the course of the illness, patients often have days when they feel well, alternating with days when they feel ill. Signs and Symptoms: The viral infection symptoms inclu ...
Hepatitis B Vaccination Declination Form
... I understand that due to my occupational exposure to blood or other potentially infectious materials I may be at risk of acquiring hepatitis B virus (HBV) infection. I have been given the opportunity to be vaccinated with hepatitis B vaccine, at no charge to myself. However, I decline hepatitis B va ...
... I understand that due to my occupational exposure to blood or other potentially infectious materials I may be at risk of acquiring hepatitis B virus (HBV) infection. I have been given the opportunity to be vaccinated with hepatitis B vaccine, at no charge to myself. However, I decline hepatitis B va ...
Hepatitis B Vaccination Declination Form
... Brenda Fitzgerald, MD, Commissioner | Nathan Deal, Governor Olugbenga Obasanjo, M.D., Ph.D., M.P.H., M.B.A. District Health Director Glinda Scott, Henry Co. Environmental Health County Manager 137 Henry Parkway, McDonough, GA 30253 Phone: (770) 288-6190 www.district4health.org ...
... Brenda Fitzgerald, MD, Commissioner | Nathan Deal, Governor Olugbenga Obasanjo, M.D., Ph.D., M.P.H., M.B.A. District Health Director Glinda Scott, Henry Co. Environmental Health County Manager 137 Henry Parkway, McDonough, GA 30253 Phone: (770) 288-6190 www.district4health.org ...
EASTERN MICHIGAN UNIVERSITY HEPATITIS B VACCINATION DECLINATION FORM
... I understand that due to my occupational exposure to blood or other potentially infectious materials, I may be at risk of acquiring hepatitis B virus (HBV) infection. I have been given the opportunity to be vaccinated with hepatitis B vaccine, at no charge to myself. ...
... I understand that due to my occupational exposure to blood or other potentially infectious materials, I may be at risk of acquiring hepatitis B virus (HBV) infection. I have been given the opportunity to be vaccinated with hepatitis B vaccine, at no charge to myself. ...
HEPATITIS B VIRUS VACCINATION DECLINATION STATEMENT
... Form EHS-BBP-02 (Revised 5/10) ______________________________________________________________________ (For assistance, please contact EHS at (402) 472-4925, or visit our web site at http://ehs.unl.edu/) ...
... Form EHS-BBP-02 (Revised 5/10) ______________________________________________________________________ (For assistance, please contact EHS at (402) 472-4925, or visit our web site at http://ehs.unl.edu/) ...
I understand that due to my occupational exposure to blood... materials, I may be at risk of acquiring hepatitis B...
... Office of Risk Management and Environmental Health & Safety HEPATITIS B VACCINATION DECLINATION FORM ...
... Office of Risk Management and Environmental Health & Safety HEPATITIS B VACCINATION DECLINATION FORM ...
HEPATITIS
... As little as 10-100 viral particles are needed to infect the host. 1/3 have evidence of past infection. Hepatitis E is similar to Hepatitis A. ...
... As little as 10-100 viral particles are needed to infect the host. 1/3 have evidence of past infection. Hepatitis E is similar to Hepatitis A. ...
Causes of Hepatitis B
... Mother to child. Pregnant women infected with HBV can pass the virus to their babies during childbirth. However, the newborn can be vaccinated to avoid getting infected in almost all cases. Talk to your doctor about being tested for hepatitis B if you are pregnant or want to become pregnant. ...
... Mother to child. Pregnant women infected with HBV can pass the virus to their babies during childbirth. However, the newborn can be vaccinated to avoid getting infected in almost all cases. Talk to your doctor about being tested for hepatitis B if you are pregnant or want to become pregnant. ...
Hepatitis B
Hepatitis B is an infectious disease caused by the hepatitis B virus (HBV) which affects the liver. It can cause both acute and chronic infections. Many people have no symptoms during the initial infection. Some develop a rapid onset of sickness with vomiting, yellowish skin, feeling tired, dark urine and abdominal pain. Often these symptoms last a few weeks and rarely does the initial infection result in death. It may take 30 to 180 days for symptoms to begin. In those who get infected around the time of birth 90% develop chronic hepatitis B while less than 10% of those infected after the age of five do. Most of those with chronic disease have no symptoms; however, cirrhosis and liver cancer may eventually develop. These complications results in the death of 15 to 25% of those with chronic disease.The virus is transmitted by exposure to infectious blood or body fluids. Infection around the time of birth or from contact with other people's blood during childhood is the most frequent method by which hepatitis B is acquired in areas where the disease is common. In areas where the disease is rare, intravenous drug use and sexual intercourse are the most frequent routes of infection. Other risk factors include working in healthcare, blood transfusions, dialysis, living with an infected person, travel in countries where the infection rate is high, and living in an institution. Tattooing and acupuncture led to a significant number of cases in the 1980s; however, this has become less common with improved sterility. The hepatitis B viruses cannot be spread by holding hands, sharing eating utensils, kissing, hugging, coughing, sneezing, or breastfeeding. The infection can be diagnosed 30 to 60 days after exposure. Diagnosis is typically by testing the blood for parts of the virus and for antibodies against the virus. It is one of five known hepatitis viruses: A, B, C, D, and E.The infection has been preventable by vaccination since 1982. Vaccination is recommended by the World Health Organization in the first day of life if possible. Two or three more doses are required at a later time for full effect. This vaccine works about 95% of the time. About 180 countries gave the vaccine as part of national programs as of 2006. It is also recommended that all blood be tested for hepatitis B before transfusion and condoms be used to prevent infection. During an initial infection, care is based on the symptoms that a person has. In those who develop chronic disease antiviral medication such as tenofovir or interferon maybe useful, however these drugs are expensive. Liver transplantation is sometimes used for cirrhosis.About a third of the world population has been infected at one point in their lives, including 240 million to 350 million who have chronic infections. Over 750,000 people die of hepatitis B each year. About 300,000 of these are due to liver cancer. The disease is now only common in East Asia and sub-Saharan Africa where between 5 and 10% of adults have chronic disease. Rates in Europe and North America are less than 1%. It was originally known as serum hepatitis. Research is looking to create foods that contain HBV vaccine. The disease may affect other great apes as well.